Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANTHARIDIN vs CAPLACIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANTHARIDIN vs CAPLACIZUMAB: Safety Overview

Metric CANTHARIDIN CAPLACIZUMAB
Total FAERS Reports 114 145
Deaths Reported 0 34
Death Rate N/A 23.4%
Hospitalizations 3 53
Average Patient Age 17.6 yrs 53.0 yrs
% Female Patients 53.3% 51.2%
FDA Approval Date Jul 21, 2023 N/A
Manufacturer Verrica Pharmaceuticals Inc. Genzyme Corporation
Route TOPICAL N/A
Marketing Status Prescription N/A